-
effectivehealthcare.ahrq.gov/sites/default/files/cer-251-integrated-pain-management-evidence-summary.pdf
October 01, 2021 - Intergrated and Comprehensive Pain Management Programs: Effectiveness and Harms: Evidence Summary
Comparative Effectiveness Review
Number 251
Integrated and Comprehensive Pain
Management Programs: Effectiveness and
Harms
Evidence Summary
Main Points
Background and Purpose
Pain affects millions …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-preventive-services-executive-summary.pdf
June 01, 2022 - Executive Summary: Comparative Effectiveness Review No. 256_Effectiveness of Telehealth for Women's Preventive Services
Comparative Effectiveness Review
Number 256
Effectiveness of Telehealth for
Women’s Preventive Services
Executive Summary
Main Points
• Based on 16 studies, outcomes of telehealth intervent…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_executive.pdf
April 01, 2013 - For CVD, mental illness may be an
independent risk factor that acts both
directly through physiological … When a study was designed to intervene on
more than one CVD risk factor (e.g., metabolic syndrome), … The antihistamine
nizatidine was not effective for any CVD risk factor
and is unlikely to be a useful
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol.pdf
January 01, 2024 - instability-high [MSI-H] or
mismatch repair-deficient [MMR-deficient], claudin, human epidermal growth factor … oxaliplatin and docetaxel; FOLFOX
= leucovorin, fluorouracil, and oxaliplatin; HER2 = human epidermal growth factor
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
August 01, 2012 - Family History would be important to mention as a clinically
relevant risk factor. … We agree with the reviewer that there is
not consistent evidence for gender as a
CKD risk factor. … We found only
inconsistent data reporting it as a CKD risk
factor, which we tried to reflect in our … We agree that leaving out family history as
a clinical risk factor for CKD was an
oversight. … Renal Data System (USRDS) and the
Behavioral Risk Factor Surveillance System (BRFSS).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
March 01, 2016 - women-hiv-protocol-160301
Source: www.effectivehealthcare.ahrq.gov
Published online: March 1, 2016
Evidence-based Practice Center Technical Br ief Protocol
Strategies for Improving the Lives of Women Aged 40 and Above Living with HIV/AIDS
I. Background and Objectives for the Systematic Review
It is p…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
March 01, 2016 - Effective
Health Care
Effective Health Care Program
2
Although the primary risk factor for gout … 1,630
o Not gout diagnosis or management or does not address key
question: N=2,716
o Study of risk factor … N=26
o Not gout diagnosis or management or does not address key question:
N=154
o Study of risk factor … urate-lowering impact of
weight loss among men with a high cardiovascular risk profile:
the Multiple Risk Factor … Starting dose is a risk
factor for allopurinol hypersensitivity syndrome: a proposed
safe starting
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/progestogens-preterm-birth_research-protocol.pdf
June 01, 2010 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: April 15, 2010
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of Progestogens for the Prevention of Preterm B…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disabilities-quality-improvement-outcomes_disposition-comments.pdf
October 15, 2012 - We have adjusted the language throughout
the report, replacing “comorbidity” with
“complicating factor … the authors explanation of this concept that they
are referring to disability as an independent risk factor … We have adjusted the language throughout
the report, replacing “comorbidity” with
“complicating factor … This is supported by
our work where we confirmed through factor analyses that ADLs and
IADLs generally … We have adjusted the language throughout
the report, replacing “comorbidity” with
“complicating factor
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-equity-protocol.pdf
January 01, 2020 - EPC Systematic Review Protocol: Achieving Health Equity in Preventive Services: Systematic Evidence Review
Evidence-based Practice Center Systematic Review Protocol
Project Title: Achieving Health Equity in Preventive Services – Systematic Evidence Review
I. Background and Objectives for the Systematic Rev…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-education-protocol.pdf
January 01, 2018 - Research Protocol: Characteristics of Existing Asthma Self-Management Education Packages
1
Evidence-based Practice Center
Technical Brief Protocol
Project Title: Characteristics of Existing Asthma Self-Management
Education Packages
I. Background and Objectives for the Technical Brief
Asthma is a ch…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-opioid-chronic-pain-surveillance-report-2.xlsx
January 01, 2021 - Table E-1. RCT QA
Table E-1. RCT quality assessment
Author,
Year Randomization Adequate? Allocation Concealment Adequate? Groups Similar at Baseline? Outcome Assessors Masked? Care Provider Masked? Patient Masked? Intention-To-Treat (ITT) Analysis Acceptable Levels of Overall Attrition and Between-Group Differences…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-opioid-chronic-pain-surveill-report-1.xlsx
January 01, 2021 - Table E-1. RCT QA
Table E-1. RCT quality assessment
Author,
Year Randomization Adequate? Allocation Concealment Adequate? Groups Similar at Baseline? Outcome Assessors Masked? Care Provider Masked? Patient Masked? Intention-to-Treat (ITT) Analysis Acceptable Levels of Overall Attrition and Between-Group Differences…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nursing-staff-shortages-rapid-research-appendix-c.xlsx
January 01, 2024 - moderate significant correlations with turnover intent (2 studies) or was identified as an important factor
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-information-exchange_executive.pdf
December 01, 2015 - The one type
of external factor cited as a facilitator was policy in the
form of Federal and State
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hnhc-evidence-summary.pdf
October 01, 2021 - Evidence Summary_Comparative Effectiveness Review No. 246_Management of High-Need High-Cost Patients: A "Best Fit" Framework Synthesis, Realist Review, and Systematic Review
Comparative Effectiveness Review
Number 246
Management of High-Need, High-Cost
Patients: A “Best Fit” Framework Synthesis,
Realist Revie…
-
effectivehealthcare.ahrq.gov/sites/default/files/politi.pdf
May 29, 2025 - Politi
Slide
1: Supporting
Shared Decisions When Clinical Evidence
is Low
Mary C. Politi, Ph.D.
Department of Surgery, Division of
Public Health Sciences
Washington University in St. Louis School of Medicine
Slide
2: Overview
• Brief overview of Shared Decis…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_executive.pdf
September 11, 2015 - metaregressions did not find any
statistically significant differences for moderation by any
program factor … because
behavioral programs seem to preferentially benefit those
with higher baseline HbA1c, this factor
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-surveillance_research-protocol.pdf
May 19, 2011 - Evidence-based Practice Center Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: May 19, 2011
Evidence-based Practice Center Review Protocol
NIH State-of-the-Science Conference:
Role of Active Surveillance in the Management of Men With Localized Prostate Cancer
I. Backg…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amended.pdf
February 07, 2025 - instability-high [MSI-H] or
mismatch repair-deficient [MMR-deficient], claudin, human epidermal growth factor … oxaliplatin and docetaxel; FOLFOX
= leucovorin, fluorouracil, and oxaliplatin; HER2 = human epidermal growth factor